Suvorexant (Belsomra) for Insomnia

被引：0
|
作者：
不详
机构：
来源：
MEDICAL LETTER ON DRUGS AND THERAPEUTICS | 2015年 / 57卷 / 1463期
关键词：
TRIAL;
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：29 / 31
页数：3
相关论文
共 50 条
  • [1] Suvorexant (Belsomra) for Insomnia
    Gauld, Andrea R.
    AMERICAN FAMILY PHYSICIAN, 2016, 93 (12) : 1016 - +
  • [2] Suvorexant approved for insomnia
    Traynor, Kate
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2014, 71 (18) : 1524 - 1524
  • [3] Suvorexant for the treatment of insomnia
    Jacobson, Laura H.
    Callander, Gabrielle E.
    Hoyer, Daniel
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2014, 7 (06) : 711 - 730
  • [4] Suvorexant for the Treatment of Insomnia in Adolescents
    Kawabe, Kentaro
    Horiuchi, Fumie
    Ochi, Marina
    Nishimoto, Kayoko
    Ueno, Shu-ichi
    Oka, Yasunori
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2017, 27 (09) : 792 - 795
  • [5] Profile of suvorexant in the management of insomnia
    Sutton, Eliza L.
    Drug Design Development and Therapy, 2015, 9 : 6035 - 6042
  • [6] Suvorexant: a promising, novel treatment for insomnia
    Lee-Iannotti, Joyce K.
    Parish, James M.
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2016, 12 : 491 - 495
  • [7] Suvorexant A Novel Therapy for the Treatment of Insomnia
    Howland, Robert H.
    JOURNAL OF PSYCHOSOCIAL NURSING AND MENTAL HEALTH SERVICES, 2014, 52 (10) : 23 - 26
  • [8] Alternative use of suvorexant (Belsomra®) for the prevention of alcohol drinking and seeking in rats with a history of alcohol dependence
    Flores-Ramirez, F. J.
    Illenberger, J. M.
    Pascasio, G. E.
    Matzeu, A.
    Mason, B. J.
    Martin-Fardon, R.
    ALCOHOL-CLINICAL AND EXPERIMENTAL RESEARCH, 2023, 47 : 165 - 165
  • [9] Alternative use of suvorexant (Belsomra®) for the prevention of alcohol drinking and seeking in rats with a history of alcohol dependence
    Flores-Ramirez, Francisco J.
    Illenberger, Jessica M.
    Pascasio, Glenn E.
    Matzeu, Alessandra
    Mason, Barbara J.
    Martin-Fardon, Remi
    FRONTIERS IN BEHAVIORAL NEUROSCIENCE, 2022, 16
  • [10] Suvorexant (Belsomra® Tablets 10, 15, and 20 mg): Japanese Drug-Use Results Survey
    Yuko Asai
    Hideki Sano
    Makoto Miyazaki
    Mika Iwakura
    Yoshikazu Maeda
    Mitsuyoshi Hara
    Drugs in R&D, 2019, 19 : 27 - 46
12345